- Home
- RNA vs NCO Comparison
RNA vs NCO Comparison
Compare RNA & NCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | NCO |
|---|---|---|
| Founded | 2025 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 146.0M |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RNA | NCO |
|---|---|---|
| Price | $8.28 | $9.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 205.4K | 67.7K |
| Earning Date | 08-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.07 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.49 | $9.83 |
| 52 Week High | $73.06 | $9.96 |
Technical Indicators
Market Signals| Indicator | RNA | NCO |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 61.86 |
| Support Level | $7.56 | $9.90 |
| Resistance Level | $8.50 | N/A |
| Average True Range (ATR) | 0.35 | 0.01 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 54.46 | 66.67 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About NCO Southern Cross Acquisition I Corp. Ordinary Shares
Southern Cross Acquisition I Corp is a blank check company formed for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.